Alpha Tau Medical Ltd

NASDAQ DRTS

Data sourced from

and

Download Data

Alpha Tau Medical Ltd Free Cash Flow for the year ending December 31, 2023: USD -24.36 M

Alpha Tau Medical Ltd Free Cash Flow is USD -24.36 M for the year ending December 31, 2023, a 1.71% change year over year. Free Cash Flow is the cash flow available to a company after deducting capital expenditures from operating cash flow, indicating its ability to generate cash for expansion, debt repayment, or dividends.

Alpha Tau Medical Ltd Free Cash Flow for the year ending December 31, 2022 was USD -24.78 M, a -68.15% change year over year.
Alpha Tau Medical Ltd Free Cash Flow for the year ending December 31, 2021 was USD -14.74 M, a -33.77% change year over year.
Alpha Tau Medical Ltd Free Cash Flow for the year ending December 31, 2020 was USD -11.02 M, a -34.32% change year over year.
Alpha Tau Medical Ltd Free Cash Flow for the year ending December 31, 2019 was USD -8.20 M.

NASDAQ: DRTS

Alpha Tau Medical Ltd

CEO	Mr. Uzi Sofer
IPO Date	March 8, 2021
Location	Israel
Headquarters	5 Kiryat Hamada Street, Jerusalem, Israel, 9777605
Employees	121
Sector	Healthcare
Industry	Biotechnology

Description

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Key trends